Results
|
|
2761.
|
|
|
|
2762.
|
|
|
|
2763.
|
|
|
|
2764.
|
|
|
|
2765.
|
|
|
|
2766.
|
|
|
|
2767.
|
|
|
|
2768.
|
|
|
|
2769.
|
|
|
|
2770.
|
|
|
|
2771.
|
|
|
|
2772.
|
|
|
|
2773.
|
|
|
|
2774.
|
|
|
|
2775.
|
|
|
|
2776.
|
|
|
|
2777.
|
|
|
|
2778.
|
|
|
|
2779.
|
Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma. [electronic resource] by
- Chawla, Sant P
- Cranmer, Lee D
- Van Tine, Brian A
- Reed, Damon R
- Okuno, Scott H
- Butrynski, James E
- Adkins, Douglas R
- Hendifar, Andrew E
- Kroll, Stew
- Ganjoo, Kristen N
Producer: 20141203
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 32
Availability: No items available.
|
|
|
2780.
|
|